YD
Yizhen Dong
Life Sciences & Healthcare
United States
Overview
Yizhen Dong is an accomplished professional in the Life Sciences & Healthcare sector, currently serving as a Healthcare & Life Sciences Growth Equity leader at Koch Disruptive Technologies. With a strong background in venture capital and management consulting, Yizhen has excelled in roles such as Co-Founder at Nox Therapeutics and Partner at Global Founders Capital, demonstrating expertise in strategic planning and financial analysis.
Work Experience
Healthcare & Life Sciences Growth Equity
2022 - 2024
Healthcare technologies and tech-enabled services Biotech software, tools, services AI/ML in biotech and healthcare
Koch Disruptive Technologies is a venture capital firm that invests in technologies to improve businesses and create new opportunities.
Co-Founder
2020 - 2023
VC-backed rare disease startup
Life Sciences & Healthcare Partner, VC & Growth Equity
2020 - 2022
Principal, Life Sciences and Healthcare VC
2016 - 2020
Strategic Planning
2013 - 2014
Real world evidence Forecasting Commercial strategies
Genentech specializes in genetic testing and personalized medicine.
Management Consultant
2011 - 2014
Real World Evidence (RWE) analytics Biotech M&A transactions Forecasting Market Research
Investment Banking
2011 - 2011
Software M&A transactions